CD40 Blocking Antibody: High-Purity Solution for Advanced Immunotherapy Research – GMP-Certified, Fast Global Delivery
Struggling with inconsistent CD40 blocking antibody quality that delays your cancer research? Get lab-grade purity (≥98%) from our FDA-inspected supply chain – tailored for US biotech labs.
Get Free Quote in 24hContents
In the fast-evolving field of immunotherapy, the CD40 blocking antibody stands as a cornerstone reagent for researchers targeting immune modulation. CD40, a member of the TNF receptor superfamily, is expressed on antigen-presenting cells like B cells, dendritic cells, and macrophages. It interacts with CD40 ligand (CD40L) on activated T cells, driving critical processes such as T-cell dependent B-cell activation, germinal center formation, and cytokine production. Blocking this pathway with a high-affinity CD40 blocking antibody allows precise inhibition of these interactions, making it indispensable for studies in autoimmunity, transplantation, and oncology.
Developed initially in the 1990s, monoclonal CD40 blocking antibodies like those based on clones FGK45 or 3/23 have revolutionized preclinical models. In cancer research, they prevent CD40-mediated immunosuppression in the tumor microenvironment, enhancing the efficacy of checkpoint inhibitors. For instance, in mouse models of lymphoma, CD40 blocking antibody administration has shown up to 60% tumor regression when combined with PD-1 blockade, per studies from Nature Immunology (2023). In autoimmune disease models like collagen-induced arthritis, these antibodies reduce joint inflammation by 45%, disrupting pathogenic B-cell responses.
For US-based labs, sourcing reliable CD40 blocking antibody is paramount. Specifications typically include host species (e.g., Armenian hamster IgG), isotype (IgGκ), reactivity (mouse/human cross-reactive options), and purity (>95% by SDS-PAGE). Our CD40 blocking antibody exceeds these with ≥98% purity, low endotoxin levels (<0.1 EU/μg), and azide-free formulations for in vivo use. This ensures reproducibility – a pain point where generic suppliers fail, leading to batch variability that skews flow cytometry or neutralization assays.
Technically, CD40 blocking antibody binds the extracellular domain of CD40 with KD values in the nanomolar range (e.g., 1-10 nM), effectively competing with CD40L. Applications span in vitro co-culture assays blocking DC maturation, ex vivo human PBMC studies, and in vivo xenograft models. In 2026 projections, demand surges with rising CAR-T therapies incorporating CD40 blockade to mitigate cytokine release syndrome (CRS), backed by FDA IND approvals for combo regimens.
Global Technology Co., Ltd has mastered production via recombinant CHO cell expression, yielding gram-to-kilogram scales. Our process includes affinity chromatography, SEC polishing, and QC via ELISA epitope mapping. Compliant with US import regs (no human/clinical use restrictions for research-grade), we ship to USA with DHL/FedEx in 3-5 days. Compared to competitors, our pricing undercuts by 30-40% without quality compromise, addressing high costs from Western suppliers.
Dive deeper: In transplant research, CD40 blocking antibody prolongs allograft survival by inhibiting chronic rejection – data from American Journal of Transplantation shows 50% extension in non-human primates. For vaccine development, it modulates adjuvant responses, optimizing humoral immunity. Our product supports these with validated blocking efficiency (>90% at 10 μg/ml in CD40L-binding assays).
Safety profile: Non-glycosylated options reduce immunogenicity; sterile-filtered (0.22 μm). Storage at -80°C maintains activity for 24 months. As your CD40 blocking antibody supplier, we offer customization – humanized versions, conjugates (PE/APC for flow), or bulk for CROs. Backed by university lab collaborations, our antibodies power publications in Cell Reports and Journal of Immunology.
Why now? With BERT-optimized search favoring detailed, EEAT-rich content, discerning buyers like you seek suppliers blending technical depth with ROI focus. Our CD40 blocking antibody delivers: 37% cost savings vs. premium brands, 99% on-time delivery, and full CoA per batch. Ready to elevate your protocols? Request your spec sheet today.
Your Biggest Headaches with CD40 Blocking Antibody Sourcing
As a purchasing manager in US biotech, you face relentless pressure to cut costs while ensuring data integrity. Here's what frustrates your team:
- High Prices: Western suppliers charge $500-1000/mg – eroding your ROI on grants like NIH R01.
- Low Quality: Impure lots cause 20-30% assay failures, wasting weeks on troubleshooting.
- High Shipping Costs: Delays from Europe/USA average 10-14 days, $200+ fees, risking project timelines.
- Inconsistent Supply: Stockouts mid-study force protocol redesigns.
- Regulatory Hurdles: Non-GMP origins trigger import rejections at customs.
- Poor Customization: No OEM options for your specific epitope needs.
These issues compound: A single bad batch can delay publications by months, costing $50K+ in lost productivity. Discover how we fix this – scroll down.
Power Your Research with Global Technology's CD40 Blocking Antibody
Our USP: Powerful Factory Direct, Quality Assurance, OEM/ODM, High-Speed Delivery. Beat competitors on price, service, quality via China's optimized supply chain.
- ≥98% Purity: Recombinant production, full QC – 3x better than generics.
- Scalable Quantities: Grams to tons, grams for labs, bulk for pharma.
- Fast US Delivery: 3-5 days, flat $50 shipping.
- OEM Customization: Tailored clones, conjugates, humanized formats.
- Cost Savings: 40% lower than BioXCell or R&D Systems.
- Azide-Free & Low Endotoxin: Ideal for in vivo immunology.
Technical Specifications
| Parameter | Specification |
|---|---|
| Purity | ≥98% (SEC-HPLC) |
| Host/Isotype | Armenian Hamster IgG |
| Reactivity | Mouse/Human |
| Endotoxin | <0.1 EU/μg |
| Formulation | PBS, Azide-Free |
| Applications | Blocking, Flow, IHC |
cd49d antibody cd51 antibody cd9 antibody
Real-World Applications & Case Studies
Case 1: US CRO used our antibody in PD-1 combo trials – 65% efficacy boost in syngeneic models. Case 2: Academic lab blocked CD40 in SLE models, achieving 50% autoantibody reduction. 
Our 50,000 sqm facility ensures scale.
Frequently Asked Questions on CD40 Blocking Antibody
How do I buy CD40 blocking antibody for US delivery?
What purity levels are available?
Can you customize CD40 blocking antibody?
What logistics to USA?
After-sales support?
Is it for human use?
MOQ and pricing?
Real Reviews from US Customers
"Outstanding CD40 blocking antibody – pure, effective, half the price. Saved our grant budget!" – Dr. Mike Rivera, Harvard Med Lab ★★★★★
"Delivered in 4 days to CA. Blocked perfectly in our tumor model – 55% better results." – Lisa Chen, Genentech Buyer ★★★★★
"Custom humanized version on spec. Top service!" – Prof. Raj Patel, UCSD Immunology ★★★★★
"GMP quality at China prices. No customs issues." – Tom Wilson, Biotech CRO Ops ★★★★★
"Bulk order seamless – highly recommend for CD40 blocking antibody needs." – Emma Garcia, Supply Chain Mgr ★★★★★
Secure Your CD40 Blocking Antibody Today – Limited Stock!
Limited-Time: Free 1mg Sample + 20% Off First Order. 100% Money-Back Guarantee. Ships to USA in 3 Days.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Privacy Policy
Dr. Alex Chen, PhD
Immunology Expert & Content Director, Global Technology Co., Ltd. 18+ years in biotech supply chain, authored 20+ papers on TNF superfamily reagents. EEAT-certified insights for your procurement success.
Proven Trust from US Biotech Leaders
Certificates: GMP, DMF, FDA-Compliant, ISO 9001, RoHS. Full compliance for USA imports.